SEC Form 4 · accession 0001209191-15-049050
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Bruce Montgomery
Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 2, 2015 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.975 | Jun 1, 2015 | A | 50,000 | A | — | Jun 1, 2020 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The options will vest in equal quarterly installments over the next year.